AR
Aranda Richard
Directeur Médical
OtherM
Insider track record
ExecutiveAcross 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Aranda Richard, Directeur Médical. Officer active across 1 company, notably Gossamer Bio, Inc.. Aggregated, 11 reports have been recorded. Split: 0 buy · 9 sells. Total volume traded: €183k. Activity tracked since 21 June 2021. The latest transaction was disclosed on 24 June 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations11 total
1,908 shares@ US$0.66050.6% of flowCommon StockSEC:0001728117-24-000078:0
4,018 shares@ US$1.32952.7% of flowCommon StockSEC:0001728117-24-000034:0
1,814 shares@ US$1.291.2% of flowCommon StockSEC:0001728117-23-000086:0
7,563 shares@ US$1.0984.3% of flowCommon StockSEC:0001728117-23-000014:0
4,757 shares@ US$12.07331.7% of flowCommon StockSEC:0001728117-22-000088:0
1,778 shares@ US$6.880.015% mcap10.6% of flowCommon StockSEC:0001728117-22-000051:0
6,278 shares@ US$8.2790.059% mcap43.4% of flowCommon StockSEC:0001728117-22-000023:0
2,377 shares@ US$12.250.031% mcap23.0% of flowCommon StockSEC:0001728117-21-000096:0
2,377 shares@ US$12.2513.7% of flowCommon StockSEC:0001728117-21-000096
15,000 shares0Common StockSEC:0001728117-21-000078
15,000 shares0Common StockSEC:0001728117-21-000078:0
About Aranda Richard
Richard Aranda is the Chief Medical Officer at Gossamer Bio, Inc. He is responsible for the medical and scientific direction of the company. His expertise in the biopharmaceutical field is essential in guiding research and the development of new treatments at Gossamer Bio, Inc.